X
Janssen claims FDA okay for would-be Tagrisso rival Rybrevant
https://pharmaphorum.com/news/janssen-claims-swift-fda-okay-for-precision-cancer-drug-rybrevant/
targeted oncology
Cytokine-Based Cancer Immunotherapies Summit
Deep Dive into Cytokine Therapies for Cancer